Provided by Tiger Trade Technology Pte. Ltd.

Novo Nordisk A/S B Shares ADRhedged

25.35
+0.11030.44%
Post-market: 25.350.00000.00%16:15 EDT
Volume:499
Turnover:12.63K
Market Cap:4.06M
PE:- -
High:25.35
Open:25.33
Low:25.33
Close:25.24
52wk High:34.36
52wk Low:19.00
Shares:160.00K
Float Shares:160.00K
Volume Ratio:0.57
T/O Rate:0.31%
Dividend:1.70
Dividend Rate:6.69%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Novo Nordisk Lawsuit Ruling Lets Some Securities Claims Move Forward

TIPRANKS
·
Aug 18

Novo Nordisk A/S Series B Stock Falls Monday, Underperforms Market

Dow Jones
·
Aug 18

Novo Nordisk downgraded to Hold from Buy at Berenberg

TIPRANKS
·
Aug 17

Novo, LightPath, Jasper, UMAC, CCEP Trending With Analysts

TIPRANKS
·
Aug 15

Novo Nordisk Completes Key Oral Semaglutide Study in Japan: What Investors Should Watch

TIPRANKS
·
Aug 14

Novo Nordisk’s SEMA-CardioDiab Hungary Study: What Real-World Oral Semaglutide Data Could Mean for NVO Investors

TIPRANKS
·
Aug 14

Novo Nordisk A/S Series B Stock Falls Thursday, Underperforms Market

Dow Jones
·
Aug 14

European Equities Traded in the US Rise in Thursday Trading

MT Newswires Live
·
Aug 13

Novo Nordisk CEO Defends Lawsuit Against Eli Lilly (LLY)

TIPRANKS
·
Aug 13

Novo CEO Says Obesity Market Won't be Winner-Take-All Battle with Lilly

Reuters
·
Aug 13

Novo Nordisk CEO Defends Lawsuit Against Eli Lilly Over Weight-Loss Drug Ads

MT Newswires Live
·
Aug 13

Health Care Roundup: Market Talk

Dow Jones
·
Aug 13

Novo Nordisk (NVO) Stock Still Looks Cheap On Earnings But Faces Growth Doubts

Simply Wall St.
·
Aug 13

Novo Nordisk Might Need Deals to Strengthen Drug Pipeline

Dow Jones
·
Aug 13

'Easy Gains Made': Berenberg Cuts Wegovy-Maker Novo Nordisk to 'hold'

Reuters
·
Aug 12

Berenberg Downgrades Novo Nordisk to Hold From Buy, Adjusts Price Target to $47 From $50

MT Newswires Live
·
Aug 12

Analysts Offer Insights on Healthcare Companies: Novo Nordisk (NVO), Pfizer (PFE) and Sana Biotechnology (SANA)

TIPRANKS
·
Aug 12

Novo Nordisk : Berenberg Cuts to Hold from Buy

THOMSON REUTERS
·
Aug 12

Novo Nordisk’s New Obesity Metabolism Trial: What Investors Should Watch

TIPRANKS
·
Aug 12

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 11